NCT02706925View on ClinicalTrials.gov

To Assess Safety, Tolerability and Pharmacokinetics of BI 443651 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

March 22, 2016

Primary Completion Date

June 12, 2016

Study Completion Date

June 13, 2016

Conditions
Healthy
Interventions
DRUG

BI 443651

DRUG

Placebo

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY